Efficacy and safety of ivacaftor in patients with cystic fibrosis who have an Arg117His-CFTR mutation: a double-blind, randomised controlled trial - Concepedia

Concepedia

Publication | Open Access

Efficacy and safety of ivacaftor in patients with cystic fibrosis who have an Arg117His-CFTR mutation: a double-blind, randomised controlled trial

DOI Full Paper Access

223

Citations

34

References

2015

Year

Richard B. Moss, Patrick A. Flume, J.S. Elborn, Jon Cooke, Steven M. Rowe, Susanna A. McColley, Ronald C. Rubenstein, Mark Higgins

The Lancet Respiratory Medicine

Antifibrotic TherapyPathologyPulmonary FibrosisArg117his-cftr MutationMedicine

References

	Year	Citations

Page 1